At the request of drugmakers, Justice Samuel Alito paused until May 11 the restrictive ruling by a lower court while the full court decides what the rules for mifepristone should be as Louisiana challenges expanded access.
Turn out it wasn't even to benefit the public, it's because a drug company lobbied them.
Otto Beta
2 comments
Turn out it wasn't even to benefit the public, it's because a drug company lobbied them.
I couldn't imagine Alito doing the right thing under any other circumstances.